EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

Synthesis, Characterization, Molecular Docking Study and Biological Evaluation of Novel 1,3,4‐Thiadiazole‐Based Heterocycles as Potential Anticancer and Antioxidant Agents

Nashwa M El-Metwaly iD, Abdulmajeed F Alrefaei iD, Hossa F Alshareef iD, Samar J Almehmadi iD, Fatimah A Alotaibi, Nadiyah M Alshammari, Manal S Ebaid iD, Hanadi A Katouah

Chemical Biology & Drug Design · 2026-07 · 108 (1)

DOI: 10.1111/cbdd.70361 ↗

At a glance

Journal article in Chemical Biology & Drug Design, published online on 2026-07-15. Written by Nashwa M El-Metwaly and 7 co-authors. Institution: Department of Chemistry, College of Science, Umm Al-Qura University, Makkah, Saudi Arabia. Major MEDLINE topics: Thiadiazoles, Antineoplastic Agents, Antioxidants, Heterocyclic Compounds. 29 references. The full text is freely available (open access, CC BY 4.0). Funded by: Northern Border University.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

The design, synthesis, and biological assessment of new heterocyclic compounds containing the 1,3,4‐thiadiazole moiety, a well‐known pharmacophore with substantial medicinal significance, are the main topics of this study. To create a variety of thiadiazole‐based heterocyclic systems, such as pyrazoles, triazoles, pyrimidines, and thiophenes, a novel cyanoacetohydrazide derivative was created and used as a crucial intermediate. IR, 1 H‐NMR, 13 C‐NMR, and mass spectrometry were the spectroscopic methods used to confirm the structures of produced compounds. The synthesized compounds' biological properties were assessed for their potential as antioxidants and anticancer agents. Several derivatives showed impressive activity in cytotoxicity tests against HePG‐2 and MCF‐7 cancer cell lines, with several compounds showing greater potency than the reference medication 5‐fluorouracil. Compounds 17 , 18 , and 13 exhibited the strongest anticancer activity, highlighting the significance of structural and electronic properties in improving biological performance. Furthermore, an assessment of the synthesized compounds' antioxidant activity revealed that they have differing levels of free radical scavenging activity, with compounds 17 and 18 exhibiting the most notable benefits, albeit still less than ascorbic acid. Electron‐donating and electron‐withdrawing groups, molecular conjugation, and lipophilicity all play a part in regulating antioxidant and anticancer actions, according to structure–activity relationship (SAR) studies. Additionally, substantial interactions between specific drugs and the EGFR tyrosine kinase domain were suggested by molecular docking studies, indicating their possible mode of action. All things considered, our work shows that thiadiazole‐based heterocycles are attractive candidates for the creation of novel antioxidants and anticancer medicines and offers insightful information for future drug design.

Subjects

MeSH terms (MEDLINE)

ThiadiazolesAntineoplastic AgentsAntioxidantsHeterocyclic CompoundsHumansMolecular Docking SimulationMCF-7 CellsHep G2 CellsErbB ReceptorsStructure-Activity RelationshipCell Line, Tumor

Author keywords

1,3,4‐Thiadiazoleanticancer activityantioxidant activityheterocyclic compoundsmolecular docking

Substances

ThiadiazolesAntineoplastic AgentsAntioxidants1,3,4-thiadiazoleErbB ReceptorsHeterocyclic Compounds

Authors and institutions

  • Department of Chemistry, College of Science, Umm Al-Qura University, Makkah, Saudi Arabia.
  • Department of Biology/Genetic and Molecular Biology Central Laboratory (GMCL), Jamoum University College, Umm Al-Qura University, Makkah, Saudi Arabia.
  • Department of Chemistry, Faculty of Science, University of Tabuk, Tabuk, Saudi Arabia.
  • Department of Chemistry, College of Science, Qassim University, Buraidah, Saudi Arabia.
  • Department of Chemistry, College of Science, Northern Border University, Arar, Saudi Arabia.

ORCID profiles: Nashwa M El-Metwaly, Abdulmajeed F Alrefaei, Hossa F Alshareef, Samar J Almehmadi, Manal S Ebaid

Funding

  • Northern Border University

Cite

APA

El-Metwaly, N. M., Alrefaei, A. F., Alshareef, H. F., Almehmadi, S. J., Alotaibi, F. A., Alshammari, N. M., Ebaid, M. S., & Katouah, H. A. (2026). Synthesis, Characterization, Molecular Docking Study and Biological Evaluation of Novel 1,3,4‐Thiadiazole‐Based Heterocycles as Potential Anticancer and Antioxidant Agents. Chemical Biology & Drug Design, 108(1). https://doi.org/10.1111/cbdd.70361

Vancouver

El-Metwaly NM, Alrefaei AF, Alshareef HF, Almehmadi SJ, Alotaibi FA, Alshammari NM, et al. Synthesis, Characterization, Molecular Docking Study and Biological Evaluation of Novel 1,3,4‐Thiadiazole‐Based Heterocycles as Potential Anticancer and Antioxidant Agents. Chemical Biology & Drug Design. 2026;108(1). doi:10.1111/cbdd.70361

BibTeX
@article{ElMetwaly2026,
  author = {El-Metwaly, Nashwa M and Alrefaei, Abdulmajeed F and Alshareef, Hossa F and Almehmadi, Samar J and Alotaibi, Fatimah A and Alshammari, Nadiyah M and Ebaid, Manal S and Katouah, Hanadi A},
  title = {Synthesis, Characterization, Molecular Docking Study and Biological Evaluation of Novel 1,3,4‐Thiadiazole‐Based Heterocycles as Potential Anticancer and Antioxidant Agents},
  journal = {Chemical Biology & Drug Design},
  year = {2026},
  volume = {108},
  number = {1},
  doi = {10.1111/cbdd.70361}
}
Start for free →